logo

For the Inventor, By the Inventor

Redwood City, CA, United States of America

Genelabs, Incorporated


USPTO Granted Patents = 17

Forward Citations = 242

Loading Chart...
Loading Chart...

27 inventors (with patents filed for the assignee):

goldMedal Gregory R Reyes (5 out of 27 patents)

silverMedal Kou M Hwang (5 out of 6 patents)

bronzeMedal Michael S McGrath (4 out of 26 patents)

4.  Su-Ying Liu (4 out of 6 patents)

5.  You M Qi (4 out of 5 patents)

6.  Theresa P Chow (3 out of 4 patents)

7.  Michael Piatak (3 out of 5 patents)

8.  Kirk E Fry (2 out of 39 patents)

9.  Valerie L Ng (2 out of 3 patents)

10.  Jen Chen (2 out of 7 patents)

11.  William Choy (2 out of 3 patents)

12.  Linda B Rabin (2 out of 2 patents)

13.  Hin-Wing Yeung (2 out of 2 patents)

14.  Jeffrey D Lifson (2 out of 2 patents)

15.  Edgar George Engleman (1 out of 46 patents)


17 patents:

1. 5443965 - Hepatitis C virus epitopes (1995-08-22),
2. 5441983 - Treatment of infection by enveloped virus with calix(N)arene compounds (1995-08-15),
3. 5409959 - Antithrombotic treatment with calix(n)arene compounds (1995-04-25),
4. 5218099 - Post-transfusion, non-A, non-B hepatitis virus polynucleotides (1993-06-08),
5. 5196452 - Macrocyclic anti-viral compound and method (1993-03-23),
6. 5169753 - Method and kit for detecting human retrovirus (1992-12-08),
7. 5166173 - Method of treating herpes simplex virus infection (1992-11-24),
8. 5166056 - Recombinant trichosanthin and coding sequence (1992-11-24),
9. 5128460 - Recombinant trichosanthin and coding sequence (1992-07-07),
10. 5108920 - Retrovirus isolated from human lymphoma cell lines (1992-04-28),
11. 5101025 - Recombinant trichosanthin and coding sequence (1992-03-31),
12. 5077390 - Purified trichosanthin and method of preparation (1991-12-31),
13. 5066579 - HTLV-I peptide antigen and assay (1991-11-19),
14. 4869903 - Method of selectively inhibiting HIV (1989-09-26),
15. 4851210 - Blood typing device (1989-07-25),
Company Overview
Genelabs, Incorporated is a biotechnology company based in Redwood City, California, specializing in the development of innovative diagnostic solutions and therapeutic products. The organization focuses on advancing healthcare through cutting-edge research in molecular biology and immunology, aiming to address unmet medical needs. With a commitment to scientific excellence, Genelabs engages in the discovery and commercialization of technologies that enhance disease detection and treatment, contributing to improved patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

17 Patents

#103 in Redwood City, CA

#4,515 in California

#18,894 in US

#35,918 in the World

Redwood City, CA (US)
Redwood City, CA, United States of America

Genelabs, Incorporated

Forward Citations = 242

27 inventors:

goldMedal Gregory R Reyes (5 out of 27 patents)

silverMedal Kou M Hwang (5 out of 6 patents)

bronzeMedal Michael S McGrath (4 out of 26 patents)

4.  Su-Ying Liu (4 out of 6 patents)

5.  You M Qi (4 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genelabs, Incorporated. Retrieved from https://idiyas.com/company/genelabs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…